Mostly Markets
Subscribe
Stocks/Financials/Life & Health Insurance

AflacAFL

Life & Health Insurance · Columbus, Georgia · In the S&P 500
High qualityPricier than peers
$123.89+0.28%After hours: $124.92 (+0.83%)At the close, 30 Oct · Prices from CNBC, may be delayed
▲ 17.2% over 1 year
Aflac over 1 yearDaily close, $, to 30 Oct 2026
$110$120$130Nov2026MarMayJulSep$123.89$110$120$130NovMarJul$123.89
Source: Nasdaq daily closes
Market value$62.11B
Price to earnings13.3x
Forward P/E16.8x
Dividend yield1.97%
Year to date+12.4%
One year+17.2%
Next earningsWed 4 Nov, after the close
SectorFinancials
52-week range (closes)
$106.20$129.55

Quality and valuation

How Aflac compares with other financials stocks. A description, not a recommendation.

Aflac and 4 life & health insurance peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.

Business quality: stronger than mostValuation: pricier than most

A stronger business than most financials companies, priced above most of them.

Aflac trades at 16.8 times the next 12 months of expected earnings, against a median of 13.0x for the 84 financials stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.

  • Revenue grew faster than the sector median: +13.6% vs +10.2%
  • Keeps more of its revenue as profit (net margin): 26.9% vs 20.7%
AFL trades at 16.8x forward earnings, above the sector medianForward p/e, Life & Health Insurance peers
PRU8.8xMET9.3xGL9.8xPFG11.6xAFL16.8xSector median 13.0xPRU8.8xMET9.3xGL9.8xPFG11.6xAFL16.8xSector median 13.0x
Source: CNBC quotes; Mostly Markets
At 13.3x earnings, AFL is cheaper than its average since Aug 2024Price over the last 12 months of reported (GAAP) diluted EPS
P/EUsual range (±1 s.d.)
10x15x20x25xAverage 15.2x2025202613.3x10x20xAverage 15.2x2025202613.3x
Source: Nasdaq prices; SEC filings

Financials

From Aflac's SEC filings, through the quarter ending 30 Jun 2026. Hover or tap a bar for its value.

Revenue fell 1.0% from a year earlierQuarterly revenue, $bn, latest Q2 ’26
$0bn$2bn$4bnQ3 ’24Q1 ’25Q3 ’25$4.1bnQ2 ’26$0bn$2bn$4bnQ3 ’24Q1 ’25Q3 ’25$4.1bnQ2 ’26
Source: SEC filings
Growth slowed to −1.0% last quarterRevenue growth, year on year, %
0%50%Q3 ’24Q1 ’25Q3 ’25−1.0%Q2 ’260%50%Q3 ’24Q1 ’25Q3 ’25−1.0%Q2 ’26
Source: SEC filings
Diluted EPS was $1.63 last quarterQuarterly diluted earnings per share, $
$0$1$2$3Q3 ’24Q1 ’25Q3 ’25$1.63Q2 ’26$0$2Q3 ’24Q1 ’25Q3 ’25$1.63Q2 ’26
Source: SEC filings
Last 12 monthsAFLSector median
Revenue growth+13.6%+10.2%
Price to earnings13.3x14.6x

Stories on Aflac

We haven't written about Aflac yet. Follow it, and its first story will show under My stocks on the front page.

Similar companies

Life & Health Insurance, by market value.

CompanyPriceTodayYTDValue
METMetLife$100.02−0.80%+26.7%$63.56B
PRUPrudential Financial$116.45−0.36%+3.2%$40.17B
PFGPrincipal Financial Group$111.63−1.78%+26.6%$23.75B
GLGlobe Life$159.08−0.85%+13.7%$12.22B